

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.08176926 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.08176926 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.73357141 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.73357141 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.30300163 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.65511055 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.65511055 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.65511055 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.55465097 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.54801980 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.43718312 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.42582029 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39552815 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.34670515 |
| 15 | cysteine metabolic process (GO:0006534) | 5.11928759 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.05370813 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98182654 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.90680506 |
| 19 | urea metabolic process (GO:0019627) | 4.85301963 |
| 20 | urea cycle (GO:0000050) | 4.85301963 |
| 21 | lysine catabolic process (GO:0006554) | 4.78806901 |
| 22 | lysine metabolic process (GO:0006553) | 4.78806901 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.72805141 |
| 24 | protein carboxylation (GO:0018214) | 4.72805141 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.64791316 |
| 26 | bile acid metabolic process (GO:0008206) | 4.61534454 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.61472933 |
| 28 | negative regulation of cell killing (GO:0031342) | 4.60445219 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60445219 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.54375072 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.54320530 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.53485227 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.49657860 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.49649634 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.45398080 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.45122636 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.43282340 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.41376957 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.32966122 |
| 40 | ethanol oxidation (GO:0006069) | 4.30978170 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.30511253 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.30418227 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.27371414 |
| 44 | regulation of complement activation (GO:0030449) | 4.23772199 |
| 45 | protein-lipid complex assembly (GO:0065005) | 4.21023227 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.17766901 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.17766901 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.17766901 |
| 49 | epoxygenase P450 pathway (GO:0019373) | 4.17696845 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.14682529 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.14682529 |
| 52 | phospholipid efflux (GO:0033700) | 4.08071483 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.06161042 |
| 54 | cellular glucuronidation (GO:0052695) | 4.04602633 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.03354971 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.01940640 |
| 57 | benzene-containing compound metabolic process (GO:0042537) | 4.01376687 |
| 58 | glutamate metabolic process (GO:0006536) | 3.98771065 |
| 59 | negative regulation of sterol transport (GO:0032372) | 3.98510101 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 3.98510101 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 3.96954294 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.95384531 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.92148857 |
| 64 | amine catabolic process (GO:0009310) | 3.92148857 |
| 65 | ketone body metabolic process (GO:1902224) | 3.91383669 |
| 66 | bile acid and bile salt transport (GO:0015721) | 3.90297952 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 3.87854194 |
| 68 | cholesterol efflux (GO:0033344) | 3.80009248 |
| 69 | fatty acid beta-oxidation (GO:0006635) | 3.79094419 |
| 70 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78544529 |
| 71 | acetyl-CoA metabolic process (GO:0006084) | 3.76886502 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75680865 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.73413211 |
| 74 | fatty acid oxidation (GO:0019395) | 3.72144848 |
| 75 | uronic acid metabolic process (GO:0006063) | 3.71667000 |
| 76 | glucuronate metabolic process (GO:0019585) | 3.71667000 |
| 77 | carboxylic acid catabolic process (GO:0046395) | 3.71500453 |
| 78 | organic acid catabolic process (GO:0016054) | 3.71500453 |
| 79 | aldehyde catabolic process (GO:0046185) | 3.69682203 |
| 80 | drug catabolic process (GO:0042737) | 3.69127228 |
| 81 | monocarboxylic acid catabolic process (GO:0072329) | 3.68759920 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67112041 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65994139 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 3.65951269 |
| 85 | lipid oxidation (GO:0034440) | 3.65816129 |
| 86 | fatty acid catabolic process (GO:0009062) | 3.63873133 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.60215200 |
| 88 | phospholipid homeostasis (GO:0055091) | 3.58588772 |
| 89 | drug transmembrane transport (GO:0006855) | 3.54289030 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53776796 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.53711263 |
| 92 | plasma lipoprotein particle organization (GO:0071827) | 3.53601725 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.52981213 |
| 94 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.51543819 |
| 95 | glycine metabolic process (GO:0006544) | 3.51493741 |
| 96 | valine metabolic process (GO:0006573) | 3.51051462 |
| 97 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.49692523 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.48503587 |
| 99 | carnitine metabolic process (GO:0009437) | 3.47150555 |
| 100 | arginine metabolic process (GO:0006525) | 3.46921297 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.46545488 |
| 102 | response to nitrosative stress (GO:0051409) | 3.44541707 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.41684783 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.41684783 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.40753153 |
| 106 | protein-lipid complex subunit organization (GO:0071825) | 3.40221331 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.39328302 |
| 108 | cofactor catabolic process (GO:0051187) | 3.38738812 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.37025152 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36635671 |
| 111 | proline metabolic process (GO:0006560) | 3.36504881 |
| 112 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.32637989 |
| 113 | NADH metabolic process (GO:0006734) | 3.29035291 |
| 114 | exogenous drug catabolic process (GO:0042738) | 3.27444295 |
| 115 | response to interleukin-15 (GO:0070672) | 3.19554078 |
| 116 | intestinal cholesterol absorption (GO:0030299) | 3.11894035 |
| 117 | regulation of apoptotic cell clearance (GO:2000425) | 3.07729659 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02558098 |
| 119 | ethanol metabolic process (GO:0006067) | 3.00600228 |
| 120 | regulation of cholesterol metabolic process (GO:0090181) | 2.97103569 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.97060361 |
| 122 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.96022990 |
| 123 | proline biosynthetic process (GO:0006561) | 2.94044481 |
| 124 | hemoglobin metabolic process (GO:0020027) | 2.91102527 |
| 125 | regulation of humoral immune response (GO:0002920) | 2.89415503 |
| 126 | intestinal absorption (GO:0050892) | 2.89396428 |
| 127 | diacylglycerol metabolic process (GO:0046339) | 2.88905700 |
| 128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87520756 |
| 129 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.86327032 |
| 130 | oxaloacetate metabolic process (GO:0006107) | 2.86232623 |
| 131 | blood coagulation, intrinsic pathway (GO:0007597) | 2.85725569 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.85117299 |
| 133 | acute-phase response (GO:0006953) | 2.83825360 |
| 134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.77835538 |
| 135 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.77022411 |
| 136 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.77022411 |
| 137 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73019212 |
| 138 | protein activation cascade (GO:0072376) | 2.68449560 |
| 139 | drug metabolic process (GO:0017144) | 2.68367203 |
| 140 | embryonic process involved in female pregnancy (GO:0060136) | 2.63197412 |
| 141 | lipoprotein metabolic process (GO:0042157) | 2.61662876 |
| 142 | angiotensin maturation (GO:0002003) | 2.61176231 |
| 143 | complement activation (GO:0006956) | 2.59594715 |
| 144 | fructose metabolic process (GO:0006000) | 2.57023256 |
| 145 | response to mercury ion (GO:0046689) | 2.55712675 |
| 146 | porphyrin-containing compound metabolic process (GO:0006778) | 2.55288296 |
| 147 | detection of bacterium (GO:0016045) | 2.54111755 |
| 148 | regulation of gamma-delta T cell activation (GO:0046643) | 2.52818045 |
| 149 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.51907458 |
| 150 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.51904041 |
| 151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.51669766 |
| 152 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.50702311 |
| 153 | lipoprotein transport (GO:0042953) | 2.50585766 |
| 154 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.48373179 |
| 155 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.48370604 |
| 156 | positive thymic T cell selection (GO:0045059) | 2.47108761 |
| 157 | omega-hydroxylase P450 pathway (GO:0097267) | 2.47063375 |
| 158 | positive regulation of blood coagulation (GO:0030194) | 2.46826776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.42898720 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.43443206 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.85212866 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.80086922 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90560584 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82800533 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.36620893 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.73874608 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.34930605 |
| 10 | * MYC_22102868_ChIP-Seq_BL_Human | 2.28519851 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26332461 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06570282 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4578676 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.96289158 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95099732 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94573657 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94068776 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90870200 |
| 19 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88771964 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 1.88676967 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85163171 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79390226 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70974257 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69114935 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68593072 |
| 26 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.67489220 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66762757 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65601168 |
| 29 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65320832 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62595815 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61562104 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60044673 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57802381 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57791701 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56698744 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56482888 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.53917087 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50207762 |
| 39 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47463141 |
| 40 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47200743 |
| 41 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47062230 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46655147 |
| 43 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45944702 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.45120489 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45103985 |
| 46 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40545480 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40237230 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39202540 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37112583 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36850371 |
| 51 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36265962 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36127252 |
| 53 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36041509 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35160669 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32937135 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32766111 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31417489 |
| 58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29577068 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.29345063 |
| 60 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27990377 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27907559 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26488114 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24457364 |
| 64 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23331942 |
| 65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20971471 |
| 66 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20958744 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.19987055 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19018111 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18742090 |
| 70 | * MYB_26560356_Chip-Seq_TH1_Human | 1.18724410 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17083763 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16247365 |
| 73 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15831421 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15643996 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14415900 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14109082 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13805668 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13480109 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13467243 |
| 80 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13436816 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10007668 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09155068 |
| 83 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08528891 |
| 84 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07987873 |
| 85 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04524533 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04486151 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03305695 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02959859 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00182398 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99258475 |
| 91 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98115392 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96450566 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94124893 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93141654 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92679374 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92581826 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91954667 |
| 98 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90649577 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90471682 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80367423 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80367423 |
| 102 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78848579 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78162632 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78014475 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75795442 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75297032 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71934400 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69206044 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68944247 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68770756 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67665647 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67418508 |
| 113 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67267101 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.65721304 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.65644445 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.65644445 |
| 117 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64347140 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62817855 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62515092 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62450298 |
| 121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61838690 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61450565 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60388128 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.59240848 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.59163621 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58616912 |
| 127 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57900503 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57850124 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57436446 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.57326055 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57142659 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56492952 |
| 133 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56398122 |
| 134 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.56311508 |
| 135 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.55502379 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.54768245 |
| 137 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.54228347 |
| 138 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.53984085 |
| 139 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.53708958 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.52747648 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.52676665 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52462695 |
| 143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52026772 |
| 144 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.51875344 |
| 145 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.51354263 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.51208545 |
| 147 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50920781 |
| 148 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50178924 |
| 149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.49616386 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48437385 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.46877800 |
| 152 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46592424 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46537518 |
| 154 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46482130 |
| 155 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.46478622 |
| 156 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.46459193 |
| 157 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46221131 |
| 158 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.46177686 |
| 159 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.46084569 |
| 160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.46037629 |
| 161 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45197824 |
| 162 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45115291 |
| 163 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.44624572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.79416327 |
| 2 | MP0005360_urolithiasis | 6.96869503 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.88860431 |
| 4 | MP0005365_abnormal_bile_salt | 5.88784132 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07410640 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.81645486 |
| 7 | MP0003252_abnormal_bile_duct | 3.62517639 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.35754156 |
| 9 | MP0003195_calcinosis | 3.09862707 |
| 10 | MP0005083_abnormal_biliary_tract | 3.08379440 |
| 11 | MP0009840_abnormal_foam_cell | 3.07965285 |
| 12 | MP0005332_abnormal_amino_acid | 2.81954769 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.72713520 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.22971656 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.22302645 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.19501662 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.14179734 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.12321488 |
| 19 | MP0000609_abnormal_liver_physiology | 2.02239448 |
| 20 | MP0008260_abnormal_autophagy | 2.01157492 |
| 21 | MP0003303_peritoneal_inflammation | 1.99673910 |
| 22 | MP0000685_abnormal_immune_system | 1.96748977 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.93182589 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.88097958 |
| 25 | MP0005025_abnormal_response_to | 1.80924684 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.79835685 |
| 27 | MP0005671_abnormal_response_to | 1.79617477 |
| 28 | MP0003868_abnormal_feces_composition | 1.67679860 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66440852 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.62134275 |
| 31 | MP0001764_abnormal_homeostasis | 1.59119534 |
| 32 | MP0009785_altered_susceptibility_to | 1.56316713 |
| 33 | MP0002419_abnormal_innate_immunity | 1.55843635 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.54131864 |
| 35 | MP0005387_immune_system_phenotype | 1.52849556 |
| 36 | MP0001790_abnormal_immune_system | 1.52849556 |
| 37 | MP0001800_abnormal_humoral_immune | 1.52407474 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.51053072 |
| 39 | MP0003866_abnormal_defecation | 1.51018882 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.44211961 |
| 41 | MP0005451_abnormal_body_composition | 1.44058796 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.43640865 |
| 43 | MP0002132_abnormal_respiratory_system | 1.41285360 |
| 44 | MP0002723_abnormal_immune_serum | 1.35655347 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.33137059 |
| 46 | MP0003879_abnormal_hair_cell | 1.33053758 |
| 47 | MP0004947_skin_inflammation | 1.31235750 |
| 48 | MP0003011_delayed_dark_adaptation | 1.30578798 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.29656191 |
| 50 | MP0002166_altered_tumor_susceptibility | 1.29224955 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.28093453 |
| 52 | MP0001819_abnormal_immune_cell | 1.27925034 |
| 53 | MP0003186_abnormal_redox_activity | 1.24998499 |
| 54 | MP0004043_abnormal_pH_regulation | 1.19797254 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.17462882 |
| 56 | MP0002398_abnormal_bone_marrow | 1.17196064 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.17144745 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.16592954 |
| 59 | MP0000604_amyloidosis | 1.13556498 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.12961561 |
| 61 | MP0002722_abnormal_immune_system | 1.11213671 |
| 62 | MP0009697_abnormal_copulation | 1.09783652 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.09722912 |
| 64 | MP0004130_abnormal_muscle_cell | 1.08043362 |
| 65 | MP0000716_abnormal_immune_system | 1.07494273 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.05675757 |
| 67 | MP0004858_abnormal_nervous_system | 1.04584789 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.03523673 |
| 69 | MP0002405_respiratory_system_inflammati | 1.03248691 |
| 70 | MP0009764_decreased_sensitivity_to | 1.02943179 |
| 71 | MP0000598_abnormal_liver_morphology | 1.00057264 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.99937414 |
| 73 | MP0005670_abnormal_white_adipose | 0.99765211 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.99524175 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.99204982 |
| 76 | MP0003878_abnormal_ear_physiology | 0.99204982 |
| 77 | MP0002254_reproductive_system_inflammat | 0.96692686 |
| 78 | MP0002429_abnormal_blood_cell | 0.95717182 |
| 79 | MP0001873_stomach_inflammation | 0.94964727 |
| 80 | MP0005647_abnormal_sex_gland | 0.93527128 |
| 81 | MP0005535_abnormal_body_temperature | 0.92357393 |
| 82 | MP0009642_abnormal_blood_homeostasis | 0.90080112 |
| 83 | MP0001756_abnormal_urination | 0.89467236 |
| 84 | MP0009763_increased_sensitivity_to | 0.89427138 |
| 85 | MP0003329_amyloid_beta_deposits | 0.87658199 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.87256440 |
| 87 | MP0008469_abnormal_protein_level | 0.86969683 |
| 88 | MP0002971_abnormal_brown_adipose | 0.84582637 |
| 89 | MP0002822_catalepsy | 0.83553050 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.83410002 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.83284098 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.80754333 |
| 93 | MP0000858_altered_metastatic_potential | 0.79877442 |
| 94 | MP0003690_abnormal_glial_cell | 0.79023547 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.77080755 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.77080755 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.77021033 |
| 98 | MP0005408_hypopigmentation | 0.74097701 |
| 99 | MP0000747_muscle_weakness | 0.73983543 |
| 100 | MP0005409_darkened_coat_color | 0.73674320 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.72952416 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.72666640 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.72429881 |
| 104 | MP0003122_maternal_imprinting | 0.71869824 |
| 105 | MP0005334_abnormal_fat_pad | 0.70746613 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.69911288 |
| 107 | MP0001661_extended_life_span | 0.66627133 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.66310116 |
| 109 | MP0005266_abnormal_metabolism | 0.65728736 |
| 110 | MP0005448_abnormal_energy_balance | 0.65131311 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.64323238 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.63196299 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.62562730 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.59557548 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.59364362 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.57995235 |
| 117 | MP0002928_abnormal_bile_duct | 0.55174014 |
| 118 | MP0003953_abnormal_hormone_level | 0.54769209 |
| 119 | MP0003075_altered_response_to | 0.51561204 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.50867738 |
| 121 | MP0003705_abnormal_hypodermis_morpholog | 0.50247730 |
| 122 | MP0002090_abnormal_vision | 0.48009714 |
| 123 | MP0003724_increased_susceptibility_to | 0.47278820 |
| 124 | MP0008872_abnormal_physiological_respon | 0.46751262 |
| 125 | MP0002269_muscular_atrophy | 0.46708265 |
| 126 | MP0008874_decreased_physiological_sensi | 0.46387231 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.46010860 |
| 128 | MP0005330_cardiomyopathy | 0.45751796 |
| 129 | MP0004147_increased_porphyrin_level | 0.45687502 |
| 130 | MP0004036_abnormal_muscle_relaxation | 0.42638898 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.42419236 |
| 132 | MP0005464_abnormal_platelet_physiology | 0.39323272 |
| 133 | MP0003646_muscle_fatigue | 0.39287354 |
| 134 | MP0005166_decreased_susceptibility_to | 0.38398559 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.37805727 |
| 136 | MP0002909_abnormal_adrenal_gland | 0.35372962 |
| 137 | MP0003959_abnormal_lean_body | 0.34678849 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.34410883 |
| 139 | MP0001984_abnormal_olfaction | 0.34138323 |
| 140 | MP0002693_abnormal_pancreas_physiology | 0.33837515 |
| 141 | MP0008873_increased_physiological_sensi | 0.33328517 |
| 142 | MP0002168_other_aberrant_phenotype | 0.32563411 |
| 143 | MP0005395_other_phenotype | 0.32184911 |
| 144 | MP0003436_decreased_susceptibility_to | 0.31129667 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.30255096 |
| 146 | MP0000579_abnormal_nail_morphology | 0.30243120 |
| 147 | MP0004264_abnormal_extraembryonic_tissu | 0.29964695 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.29783763 |
| 149 | MP0006082_CNS_inflammation | 0.28921652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.74729751 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.40380005 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.17331098 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.59900526 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.57844085 |
| 6 | Xanthomatosis (HP:0000991) | 5.54601885 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.36815518 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.90427878 |
| 9 | Ketosis (HP:0001946) | 4.60199863 |
| 10 | Complement deficiency (HP:0004431) | 4.55845067 |
| 11 | Hyperammonemia (HP:0001987) | 4.47165190 |
| 12 | Hypoglycemic coma (HP:0001325) | 4.30913475 |
| 13 | Hyperglycinemia (HP:0002154) | 4.13990715 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.11891183 |
| 15 | Hyperglycinuria (HP:0003108) | 4.05383519 |
| 16 | Joint hemorrhage (HP:0005261) | 4.02150087 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.96225938 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.95270331 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92575390 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.92575390 |
| 21 | Epidermoid cyst (HP:0200040) | 3.89491821 |
| 22 | Ketoacidosis (HP:0001993) | 3.89369048 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.84757597 |
| 24 | Poikilocytosis (HP:0004447) | 3.80474465 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.77589937 |
| 26 | Fat malabsorption (HP:0002630) | 3.77506170 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.77306758 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.76476790 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.69423983 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.67987734 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.57602242 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.55618883 |
| 33 | Eczematoid dermatitis (HP:0000976) | 3.46055998 |
| 34 | Hemorrhage of the eye (HP:0011885) | 3.45405971 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43201625 |
| 36 | Reticulocytosis (HP:0001923) | 3.28207264 |
| 37 | Gout (HP:0001997) | 3.25470603 |
| 38 | Abnormality of complement system (HP:0005339) | 3.14997473 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.13551165 |
| 40 | Myositis (HP:0100614) | 3.11465720 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.09593787 |
| 42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.08616153 |
| 43 | Metabolic acidosis (HP:0001942) | 3.00032578 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.99663099 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.95719680 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.92697830 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.92697830 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90721851 |
| 49 | Orchitis (HP:0100796) | 2.89912825 |
| 50 | Hypochromic anemia (HP:0001931) | 2.89756457 |
| 51 | Steatorrhea (HP:0002570) | 2.87510635 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.81708455 |
| 53 | Optic neuritis (HP:0100653) | 2.81708455 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.81344791 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80726192 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.79153416 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.77659618 |
| 58 | Lethargy (HP:0001254) | 2.72638838 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.71343768 |
| 60 | Cerebral edema (HP:0002181) | 2.65274057 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.63275888 |
| 62 | Increased serum ferritin (HP:0003281) | 2.62554674 |
| 63 | Skin nodule (HP:0200036) | 2.60653986 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.57686542 |
| 65 | Purpura (HP:0000979) | 2.55685734 |
| 66 | Vascular calcification (HP:0004934) | 2.55223468 |
| 67 | Cholelithiasis (HP:0001081) | 2.52357778 |
| 68 | Pulmonary embolism (HP:0002204) | 2.52028734 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 2.50900251 |
| 70 | Late onset (HP:0003584) | 2.50830834 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.46841653 |
| 72 | Spontaneous abortion (HP:0005268) | 2.42492111 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.41481778 |
| 74 | Myocardial infarction (HP:0001658) | 2.41397705 |
| 75 | Exercise-induced myalgia (HP:0003738) | 2.33911809 |
| 76 | Vomiting (HP:0002013) | 2.33881555 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.32174740 |
| 78 | Abnormality of macrophages (HP:0004311) | 2.30456362 |
| 79 | Myoglobinuria (HP:0002913) | 2.30379856 |
| 80 | Brushfield spots (HP:0001088) | 2.28696201 |
| 81 | Irritability (HP:0000737) | 2.27745028 |
| 82 | Meningitis (HP:0001287) | 2.26453109 |
| 83 | Joint swelling (HP:0001386) | 2.24978972 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.23426326 |
| 85 | Cholecystitis (HP:0001082) | 2.22495556 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.22495556 |
| 87 | Mitral stenosis (HP:0001718) | 2.20694824 |
| 88 | Renal cortical cysts (HP:0000803) | 2.19696353 |
| 89 | Nephritis (HP:0000123) | 2.19665450 |
| 90 | Pancreatitis (HP:0001733) | 2.19450609 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.19125074 |
| 92 | Alkalosis (HP:0001948) | 2.17289681 |
| 93 | Polycythemia (HP:0001901) | 2.17150424 |
| 94 | Vasculitis (HP:0002633) | 2.16924392 |
| 95 | Malnutrition (HP:0004395) | 2.16769055 |
| 96 | Neonatal onset (HP:0003623) | 2.16250962 |
| 97 | Acanthocytosis (HP:0001927) | 2.15972798 |
| 98 | Cerebral palsy (HP:0100021) | 2.15946673 |
| 99 | Epistaxis (HP:0000421) | 2.15820935 |
| 100 | Colitis (HP:0002583) | 2.15275450 |
| 101 | Proximal tubulopathy (HP:0000114) | 2.14923239 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.14712651 |
| 103 | Encephalitis (HP:0002383) | 2.13913803 |
| 104 | Myopathic facies (HP:0002058) | 2.12276464 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.12154516 |
| 106 | Increased purine levels (HP:0004368) | 2.10050823 |
| 107 | Hyperuricemia (HP:0002149) | 2.10050823 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 2.09150731 |
| 109 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09138457 |
| 110 | Hypochromic microcytic anemia (HP:0004840) | 2.08641434 |
| 111 | Gastrointestinal inflammation (HP:0004386) | 2.07988322 |
| 112 | Mediastinal lymphadenopathy (HP:0100721) | 2.07840469 |
| 113 | Amyloidosis (HP:0011034) | 2.07415463 |
| 114 | Pustule (HP:0200039) | 2.07224169 |
| 115 | Arterial thrombosis (HP:0004420) | 2.07129391 |
| 116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06218236 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06218236 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06218236 |
| 119 | Glycosuria (HP:0003076) | 2.05857431 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 2.05857431 |
| 121 | Spastic diplegia (HP:0001264) | 2.05684521 |
| 122 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04955271 |
| 123 | Enlarged kidneys (HP:0000105) | 2.04456428 |
| 124 | Rhabdomyolysis (HP:0003201) | 2.04135520 |
| 125 | Mucopolysacchariduria (HP:0008155) | 2.03026764 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03026764 |
| 127 | Opisthotonus (HP:0002179) | 1.99912828 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.99195199 |
| 129 | Hyperglycemia (HP:0003074) | 1.98769033 |
| 130 | Gingivitis (HP:0000230) | 1.98742860 |
| 131 | Inflammation of the large intestine (HP:0002037) | 1.98311866 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97099102 |
| 133 | Obstructive lung disease (HP:0006536) | 1.97099102 |
| 134 | Flat acetabular roof (HP:0003180) | 1.97052061 |
| 135 | Esophageal varix (HP:0002040) | 1.95258633 |
| 136 | Glomerulonephritis (HP:0000099) | 1.95025997 |
| 137 | Symptomatic seizures (HP:0011145) | 1.92770822 |
| 138 | Recurrent bacterial skin infections (HP:0005406) | 1.92249425 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.91412484 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.91412484 |
| 141 | Microcytic anemia (HP:0001935) | 1.89817255 |
| 142 | Gangrene (HP:0100758) | 1.89455018 |
| 143 | Anorexia (HP:0002039) | 1.86312098 |
| 144 | Menorrhagia (HP:0000132) | 1.86263644 |
| 145 | Acute hepatic failure (HP:0006554) | 1.86232325 |
| 146 | Pulmonary infiltrates (HP:0002113) | 1.86115320 |
| 147 | Gingival bleeding (HP:0000225) | 1.85138600 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.84260261 |
| 149 | Hypophosphatemia (HP:0002148) | 1.83455879 |
| 150 | Recurrent fungal infections (HP:0002841) | 1.83180540 |
| 151 | Keratoconjunctivitis (HP:0001096) | 1.81747018 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.81687459 |
| 153 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80648651 |
| 154 | Abnormality of reticulocytes (HP:0004312) | 1.80491339 |
| 155 | Rickets (HP:0002748) | 1.79765992 |
| 156 | Cellulitis (HP:0100658) | 1.78906777 |
| 157 | Elevated hepatic transaminases (HP:0002910) | 1.77749919 |
| 158 | Hepatic necrosis (HP:0002605) | 1.77590058 |
| 159 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76444347 |
| 160 | Thrombophlebitis (HP:0004418) | 1.75689593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.45077977 |
| 2 | ERN1 | 3.87898707 |
| 3 | FGFR4 | 3.70798134 |
| 4 | SIK1 | 3.67829784 |
| 5 | INSRR | 3.32268054 |
| 6 | PRPF4B | 2.78226428 |
| 7 | TAOK3 | 2.64293451 |
| 8 | RIPK4 | 2.13651319 |
| 9 | TESK2 | 2.13566913 |
| 10 | PINK1 | 1.88831343 |
| 11 | ICK | 1.87784819 |
| 12 | TRIB3 | 1.84571464 |
| 13 | EEF2K | 1.82704694 |
| 14 | PIK3CG | 1.73882475 |
| 15 | ERBB4 | 1.72755856 |
| 16 | TYK2 | 1.69352042 |
| 17 | MAP2K4 | 1.67271498 |
| 18 | EPHB1 | 1.60248107 |
| 19 | MAP3K7 | 1.58534019 |
| 20 | SMG1 | 1.55245171 |
| 21 | FES | 1.51061765 |
| 22 | MST1R | 1.49071503 |
| 23 | MAPK15 | 1.47648699 |
| 24 | PKN2 | 1.47400612 |
| 25 | SIK2 | 1.44521564 |
| 26 | FLT3 | 1.44349494 |
| 27 | MAPK11 | 1.40549525 |
| 28 | WNK4 | 1.36857127 |
| 29 | DAPK2 | 1.36111178 |
| 30 | OBSCN | 1.34563929 |
| 31 | FGFR2 | 1.29256658 |
| 32 | TAOK1 | 1.27981111 |
| 33 | PTK6 | 1.27689276 |
| 34 | CDK12 | 1.27689136 |
| 35 | EPHA3 | 1.23782755 |
| 36 | JAK1 | 1.21246399 |
| 37 | FRK | 1.20969636 |
| 38 | PHKG2 | 1.14864095 |
| 39 | PHKG1 | 1.14864095 |
| 40 | MAPKAPK3 | 1.14677755 |
| 41 | CSF1R | 1.14248981 |
| 42 | RIPK1 | 1.13722888 |
| 43 | LMTK2 | 1.13324996 |
| 44 | TNK2 | 1.13038803 |
| 45 | JAK2 | 1.12021979 |
| 46 | IRAK4 | 1.11622498 |
| 47 | TXK | 1.10620649 |
| 48 | SCYL2 | 1.09711145 |
| 49 | BTK | 1.09090646 |
| 50 | SYK | 1.08509807 |
| 51 | PRKAA2 | 1.07140289 |
| 52 | MYLK | 1.04510862 |
| 53 | MAP2K3 | 1.03862092 |
| 54 | NEK9 | 0.97423079 |
| 55 | MAP3K3 | 0.95054468 |
| 56 | TBK1 | 0.93924124 |
| 57 | BLK | 0.93656738 |
| 58 | MAP3K14 | 0.93358954 |
| 59 | MAP3K13 | 0.90225351 |
| 60 | TIE1 | 0.89085812 |
| 61 | JAK3 | 0.88422085 |
| 62 | HCK | 0.84539117 |
| 63 | MARK2 | 0.84377860 |
| 64 | OXSR1 | 0.84328021 |
| 65 | SIK3 | 0.83717787 |
| 66 | MAP2K6 | 0.83441966 |
| 67 | MATK | 0.83164181 |
| 68 | IKBKB | 0.79844747 |
| 69 | MAPK12 | 0.78611212 |
| 70 | PRKAA1 | 0.78387660 |
| 71 | CAMK2G | 0.78082692 |
| 72 | SGK3 | 0.76611691 |
| 73 | PDK4 | 0.76313188 |
| 74 | PDK3 | 0.76313188 |
| 75 | GRK6 | 0.75949017 |
| 76 | ABL2 | 0.74854189 |
| 77 | TTN | 0.73970636 |
| 78 | SGK223 | 0.73427236 |
| 79 | SGK494 | 0.73427236 |
| 80 | CDK4 | 0.73418847 |
| 81 | STK38L | 0.73296916 |
| 82 | LCK | 0.72843448 |
| 83 | RPS6KA2 | 0.72592874 |
| 84 | MAP3K11 | 0.72380515 |
| 85 | FGR | 0.72299723 |
| 86 | WNK3 | 0.70764261 |
| 87 | PAK3 | 0.70733479 |
| 88 | EPHA4 | 0.70061892 |
| 89 | IRAK3 | 0.69076952 |
| 90 | PRKCZ | 0.68758851 |
| 91 | CDK6 | 0.68589479 |
| 92 | ERBB2 | 0.67451745 |
| 93 | MAP3K2 | 0.67412450 |
| 94 | MAP3K10 | 0.67377564 |
| 95 | CAMKK1 | 0.67057136 |
| 96 | KDR | 0.66863498 |
| 97 | LATS1 | 0.66852448 |
| 98 | PRKACG | 0.66344213 |
| 99 | MAP3K1 | 0.66249775 |
| 100 | LYN | 0.66144295 |
| 101 | HIPK2 | 0.65619522 |
| 102 | PRKCQ | 0.65546404 |
| 103 | RPS6KL1 | 0.63841885 |
| 104 | RPS6KC1 | 0.63841885 |
| 105 | MET | 0.62890897 |
| 106 | IKBKE | 0.62438252 |
| 107 | PDPK1 | 0.61800175 |
| 108 | SGK2 | 0.60233981 |
| 109 | NEK6 | 0.59116292 |
| 110 | MAP2K1 | 0.58560303 |
| 111 | CSK | 0.58416788 |
| 112 | PIM1 | 0.57632984 |
| 113 | CDC42BPA | 0.56825662 |
| 114 | MAPKAPK2 | 0.56773939 |
| 115 | DYRK1B | 0.56258430 |
| 116 | CAMK1D | 0.56020887 |
| 117 | PKN1 | 0.55289756 |
| 118 | BMPR2 | 0.55279379 |
| 119 | STK39 | 0.54278536 |
| 120 | MAPK4 | 0.54044023 |
| 121 | GSK3A | 0.52537971 |
| 122 | PTK2 | 0.50700013 |
| 123 | BMX | 0.49791920 |
| 124 | PBK | 0.49544157 |
| 125 | MUSK | 0.49174639 |
| 126 | FYN | 0.48966730 |
| 127 | MAP4K1 | 0.48623507 |
| 128 | TAOK2 | 0.47207021 |
| 129 | RPS6KA6 | 0.46796751 |
| 130 | MAPK7 | 0.46767947 |
| 131 | GRK1 | 0.46487231 |
| 132 | CHUK | 0.46108271 |
| 133 | LRRK2 | 0.45748266 |
| 134 | RPS6KB1 | 0.44364442 |
| 135 | PRKCH | 0.43072231 |
| 136 | FGFR3 | 0.42387902 |
| 137 | MAP2K2 | 0.42138788 |
| 138 | ARAF | 0.42112145 |
| 139 | PDK1 | 0.40231756 |
| 140 | MAP3K5 | 0.40157250 |
| 141 | TGFBR2 | 0.39839624 |
| 142 | PRKD1 | 0.39826702 |
| 143 | RET | 0.39453808 |
| 144 | PIK3CA | 0.39163760 |
| 145 | ITK | 0.37737828 |
| 146 | PDK2 | 0.35569530 |
| 147 | KSR2 | 0.34013019 |
| 148 | CAMK4 | 0.32914222 |
| 149 | ZAP70 | 0.32913146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.05587264 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28296598 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23943299 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06979691 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75209146 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71217128 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68520200 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67510617 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55324285 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55027284 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41236517 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29615040 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27453714 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.27244556 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23229995 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15716135 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.13596044 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01362388 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87411012 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86875576 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86176388 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84213248 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83734440 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80549387 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76209759 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72203033 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68956152 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59429994 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55396488 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55216864 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54011200 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.53177351 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53034822 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51983584 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45683470 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.43094875 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42271594 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42228658 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41515734 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40108783 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39448873 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36686200 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.30871165 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23918995 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23750262 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20833605 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17622293 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13301721 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11414693 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11088535 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09910187 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08081822 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04452362 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02719714 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00455178 |
| 56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99397720 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97953214 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91969701 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90763453 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90704714 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88607459 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88487786 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83785017 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83478319 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79639797 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79294981 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78937176 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78900603 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.77677546 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71509325 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70774371 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68658757 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67465178 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66045411 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65283591 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.64638253 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59863167 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56424503 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.55906151 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54812473 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51005567 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50872164 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.49542834 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48418046 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48322120 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48308454 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44652761 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43702848 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43416229 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.39396998 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.37840046 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37471861 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37451814 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37355731 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37351832 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37303311 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37123067 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36781604 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.36680007 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34977693 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34263752 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33430654 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31857512 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.31347766 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29923875 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.29591850 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27062608 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.23695412 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21262524 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19909749 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19751509 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17875835 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07385926 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01377255 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1611865 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1416622 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1158488 |
| 118 | Protein export_Homo sapiens_hsa03060 | -0.1128989 |
| 119 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1111573 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1083522 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1031378 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | -0.1008398 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1002458 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0893367 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0810703 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0789460 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0741717 |
| 128 | Lysosome_Homo sapiens_hsa04142 | -0.0696107 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0639622 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0553415 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0216576 |
| 132 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0144104 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0081032 |

